Doug Roeder
Director/Board Member chez SENSEONICS HOLDINGS, INC.
Fortune : 322 842 $ au 31/03/2024
Profil
Douglas A.
Roeder is currently the Director at Ivantis, Inc. He is also an Independent Director at Senseonics Holdings, Inc. since 2015 and a Managing Partner at Delphi Ventures, Inc. since 2000.
Previously, Mr. Roeder held positions as a Director at Boston Scientific Corp., TriVascular, Inc., Anulex Technologies, Inc., Nuvesse Skin Therapies, Inc., EBR Systems, Inc., Vibrynt, Inc., Tandem Diabetes Care, Inc., Evalve, Inc., Senseonics, Inc., Labcyte, Inc., TranS1, Inc., Soteira, Inc., Trivascular Technologies, Inc., Trivascular2, Inc., Alex.
Brown & Sons, Inc., and Putnam Associates LLC.
Mr. Roeder completed his undergraduate degree at Dartmouth College in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/08/2023 | 607 988 ( 0,11% ) | 322 842 $ | 31/03/2024 |
Postes actifs de Doug Roeder
| Sociétés | Poste | Début |
|---|---|---|
| SENSEONICS HOLDINGS, INC. | Director/Board Member | 01/12/2015 |
Delphi Ventures, Inc.
 Delphi Ventures, Inc. Investment ManagersFinance Delphi Ventures Inc (Delphi Ventures) is a venture capital firm founded in 1988 by James Bochnowski. The firm is headquartered in San Mateo, California. | Private Equity Analyst | 01/01/1998 |
Ivantis, Inc.
 Ivantis, Inc. Medical SpecialtiesHealth Technology Ivantis, Inc. develops technology to treat ophthalmic diseases. The firm develops solutions for glaucoma and offers an intracanalicular scaffold or implantable device that relieves high intraocular pressures in patients. It provides its solutions for use in clinical trials to ophthalmology specialists. Ivantis was founded in 2007 and is headquartered in Irvine, CA. | Director/Board Member | 26/05/2010 |
Anciens postes connus de Doug Roeder
| Sociétés | Poste | Fin |
|---|---|---|
| TANDEM DIABETES CARE, INC. | Director/Board Member | 25/05/2022 |
| TRIVASCULAR TECHNOLOGIES INC | Director/Board Member | 03/02/2016 |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Director/Board Member | 01/12/2015 |
Soteira, Inc.
 Soteira, Inc. Medical SpecialtiesHealth Technology Soteira, Inc. manufactures and markets spinal products. The firm develops systems for the treatment of vertebral compression fractures in patients with osteoporosis, cancer, traumatic injuries, and degenerative diseases of the spine. The company was founded by John E. Corcoran in 2004 and is headquartered in Natick, MA. | Director/Board Member | 31/01/2014 |
Trivascular2, Inc.
 Trivascular2, Inc. Medical SpecialtiesHealth Technology Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare. | Director/Board Member | 02/12/2011 |
Formation de Doug Roeder
| Dartmouth College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Distribution Services |
| EBR SYSTEMS, INC. | Health Technology |
| TANDEM DIABETES CARE, INC. | Health Technology |
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| Entreprise privées | 15 |
|---|---|
TriVascular, Inc.
 TriVascular, Inc. Medical SpecialtiesHealth Technology TriVascular, Inc. develops and manufactures medical devices. It provides devices and procedures for treating abdominal aortic aneurysms and endovascular grafts. The company was founded by Michael V. Chobotov, Robert G. Whirley, and Joseph W. Humphrey in 1998 and is headquartered in Irvine, CA. | Health Technology |
Anulex Technologies, Inc.
 Anulex Technologies, Inc. Medical SpecialtiesHealth Technology Anulex Technologies, Inc. develops medical technologies. It focuses on the research and development of medical technologies to preserve and repair soft tissue of the spine for patients undergoing a surgical procedure to remove a herniated disc. The company was founded in 2001 by Matthew M. Burns and is headquartered in Minneapolis, MN. | Health Technology |
Nuvesse Skin Therapies, Inc.
 Nuvesse Skin Therapies, Inc. Medical DistributorsDistribution Services Nuvesse Skin Therapies, Inc. provides integrated wound management systems and personalized, direct-to-patient treatment solutions. Its products enables clinicians to document care through simple, web- and phone-based assessment tools, and to order personalized antimicrobial wound dressings. The company was founded by Oleg Siniaguine, David A. Richard and Dennis E. Condon in 2004 and is headquartered in Castro Valley, CA. | Distribution Services |
Vibrynt, Inc.
 Vibrynt, Inc. Medical SpecialtiesHealth Technology Vibrynt, Inc. develops medical devices for obesity treatment. It offers experimental device for the treatment of morbid obesity. The company was founded on January 5, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Ivantis, Inc.
Ivantis, Inc. Medical SpecialtiesHealth Technology Ivantis, Inc. develops technology to treat ophthalmic diseases. The firm develops solutions for glaucoma and offers an intracanalicular scaffold or implantable device that relieves high intraocular pressures in patients. It provides its solutions for use in clinical trials to ophthalmology specialists. Ivantis was founded in 2007 and is headquartered in Irvine, CA. | Health Technology |
| Alex. Brown & Sons, Inc. | Finance |
Evalve, Inc.
 Evalve, Inc. Medical SpecialtiesHealth Technology Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Senseonics, Inc.
Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Technology |
Labcyte, Inc.
 Labcyte, Inc. Medical/Nursing ServicesHealth Services Labcyte, Inc. operates as a biotechnology tools company that manufactures and markets echo liquid handling systems. It offers liquid handling, automation and consumables. The company was founded by Richard Nathan Ellson and Mark D. Fischer-Colbrie and A. Mark Bramwell in October 2003 and is headquartered in Sunnyvale, CA. | Health Services |
TranS1, Inc.
 TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | Health Technology |
Delphi Ventures, Inc.
Delphi Ventures, Inc. Investment ManagersFinance Delphi Ventures Inc (Delphi Ventures) is a venture capital firm founded in 1988 by James Bochnowski. The firm is headquartered in San Mateo, California. | Finance |
Soteira, Inc.
Soteira, Inc. Medical SpecialtiesHealth Technology Soteira, Inc. manufactures and markets spinal products. The firm develops systems for the treatment of vertebral compression fractures in patients with osteoporosis, cancer, traumatic injuries, and degenerative diseases of the spine. The company was founded by John E. Corcoran in 2004 and is headquartered in Natick, MA. | Health Technology |
Trivascular Technologies, Inc.
 Trivascular Technologies, Inc. Medical SpecialtiesHealth Technology Trivascular Technologies, Inc. operates as a medical device company developing and commercializing technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company was founded on July 11, 2007 and is headquartered in Santa Rosa, CA. | Health Technology |
Trivascular2, Inc.
Trivascular2, Inc. Medical SpecialtiesHealth Technology Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare. | Health Technology |
Putnam Associates LLC
 Putnam Associates LLC Miscellaneous Commercial ServicesCommercial Services Putnam Associates LLC engages in the provision of strategic consulting serving biopharmaceutical, diagnostics, and medical device clients. It specializes in corporate strategy, portfolio licensing and development strategy, new product, established products and franchise strategy, pricing, reimbursement and market access, and other related strategic projects. The company was founded by Kevin J. Gorman in 1988 and is headquartered in Boston, MA. | Commercial Services |
